The Economic Times daily newspaper is available online now.

    Will take one-and-a-half to two years for India to develop vaccine for COVID-19: Health Ministry

    Synopsis

    The novel coronavirus has affected 73 people in India, including 17 foreign nationals. The 17 affected foreign nationals include 16 Italians and a Canadian patient. The health ministry on Thursday asked people not to panic in the wake of increasing number of coronavirus cases in the country saying the focus is on preventive approach.

    Vaccine---AFPAFP
    Representative Image
    NEW DELHI: Senior health ministry officials said on Thursday that it will take around one-and-a-half to two years for India to develop a vaccine for novel coronavirus even with expedited clinical trials and approvals.
    The novel coronavirus has affected 74 people in the country, including 17 foreign nationals.

    The 17 affected foreign nationals include 16 Italians and a Canadian patient.

    Raman R Gangakhedkar, head of the Epidemiology and Communicable Diseases-I (ECD-I), Division of ICMR said the National Institute of Virology in Pune has been successful in isolating the virus.

    "There are two ways of going for vaccine preparation. One is either you look at the sequences of the gene which then may lead to development of antibodies, or you actually have the strain and then you try to develop a vaccine which is always an easier option," he said.

    "Coronavirus is difficult to isolate. But the efforts of scientists of National Institute of Virology (NIV) Pune have been successful and about 11 isolates of coronavirus are available which is a prime requisite for doing any kind of research related to viruses. Even with expedited clinical trials and approvals, it will take not less than around one-and-a-half to two years to develop a vaccine," Gangakhedkar asserted.

    He said in certain viruses even if vaccines are given, when the infection tends to occur, there could be a flare-up and the severity of the infection is likely to increase.

    "So, both ways if you actually look at it, we need to factor the part that it could take a long time, and there could be potential hazards. The reality is the virus is here. First, we must try to prevent it as much as possible, contain it and wait for things to happen," the official added.

    Gangakhedkar said the Indian government has made 52 laboratories functional for testing samples, while 57 labs have been designated for helping in sample collection for COVID-19 to enhance capacity for diagnosis and detection of the disease.

    "We have around 1 lakh testing kits and additional kits have been ordered," another health ministry official said.

    The health ministry on Thursday asked people not to panic in the wake of increasing number of coronavirus cases in the country saying the focus is on preventive approach and there are adequate facilities available for testing.

    It said there is no instance of any community transmission, adding there has been only local transmission.


    (You can now subscribe to our Economic Times WhatsApp channel)
    (Catch all the Business News, Breaking News, Budget 2024 News, Budget 2024 Live Coverage, Events and Latest News Updates on The Economic Times.)

    Download The Economic Times News App to get Daily Market Updates & Live Business News.

    Subscribe to The Economic Times Prime and read the ET ePaper online.

    ...more

    (You can now subscribe to our Economic Times WhatsApp channel)
    (Catch all the Business News, Breaking News, Budget 2024 News, Budget 2024 Live Coverage, Events and Latest News Updates on The Economic Times.)

    Download The Economic Times News App to get Daily Market Updates & Live Business News.

    Subscribe to The Economic Times Prime and read the ET ePaper online.

    ...more
    The Economic Times

    Stories you might be interested in